Recruitment & Retention Part 2 2014 - The "Far Side" of Recruitment and Retention Part 2 - Retention

Overview: High attrition rates are not only frustrating and costly, but the also pose a risk to the interpretation and validity of research findings. This problem is extremely important in translational research where the goal is to create effective treatment programs that can be widely employed and that are useful to large numbers of people across a broad geographical range.
Because of the threat to scientific integrity and validity, recent research has focused on the drop put problem, asking two questions: 1.) What are the characteristics of participants who are more likely to dropout or become non-compliant? And 2.) What strategies are most helpful in improving rates of volunteer retention and adherence? As with the recruitment process, we can also apply "the Leaky Pipe Analogy". We need to see where "the pipe" is leaking and then fix the leaks.
Why should you attend: Efficient subject recruitment is the key to timely completion of a clinical trial. Today, the pharmaceutical industry is faced with rising costs and is increasingly under scrutiny. The data contained on this slide is from a CenterWatch Survey conducted in 2002.
In weight loss and lifestyle change research, the average drop-out rate was 32% according to a paper published un 1999 by Davis and Addis. This figure can be higher depending on the patient population, the length of the study, and the demands of the protocol. In clinical research, each subject represents a significant amount of time, effort and other resources, so high drop out rates are very costly.
Areas Covered in the Session:
Fixing the "leak"
Anatomy of a retention plan.
Developing a relationship with your volunteer
Sings and symptoms of possible attrition
Potential causes of attrition
Recognizing the barriers to participation
Understanding volunteer concerns
Retention strategies and solutions
Who Will Benefit:
Principal Investigators
Clinical Research Coordinators
Clinical Research Managers
Clinical Research Associates
Mark Koscin, M.T., CCRA, ACRP has more than 27 years of experience as a medical technologist and Clinical Research Associate (CRA) overseeing the implementation of trials across a diversity of applications and delivery environments including: respiratory, cardiovascular, metabolic diseases, gastro-intestinal diseases, neurological, anesthesia, gene therapy, stem cell, surgical devices, women’s health, virology, and infectious disease. Mr. Koscin has held positions with Hoffman La-Roche, Baxter, Merck, Schering-Plough, Bristol Myers Squibb, Sanofi Aventis, and others. As a Clinical Research Associate, International Project Manager, and Regulatory Compliance & Training Officer, Mr. Koscin has extensive industry experience. Mr. Koscin is the Former Lead Forum Chair for the Association of Clinical Research Associates (ACRP) and also is a Past Member of the Marketing and Communications Committee. Currently Mr. Koscin is a Principal CRA with a major Clinical Rsearch Organization. Mr. Koscin also holds a position as adjunct faculty at Rutgers University for the graduate certificate course Pathways in Clinical Research and holds an appointment on the ACRP Ethics Committee. Mr. Koscin presents regularly at professional meetings and symposiums.
MentorHealth
Roger Steven
Phone No: 800-385-1607
FaX: 302-288-6884
webinars-AT-mentorhealth.com
Event Link: http://bit.ly/1waIZ4D
http://www.mentorhealth.com/